These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 2902493)

  • 1. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor.
    Edwards CR; Stewart PM; Burt D; Brett L; McIntyre MA; Sutanto WS; de Kloet ER; Monder C
    Lancet; 1988 Oct; 2(8618):986-9. PubMed ID: 2902493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal 11-beta-hydroxysteroid dehydrogenase: a mechanism ensuring mineralocorticoid specificity.
    Edwards CR
    Horm Res; 1990; 34(3-4):114-7. PubMed ID: 1966561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specificity of the human mineralocorticoid receptor: clinical clues to a biological conundrum.
    Edwards CR; Burt D; Stewart PM
    J Steroid Biochem; 1989 Jan; 32(1B):213-6. PubMed ID: 2536449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
    Edwards CR; Stewart PM
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.
    Funder JW; Pearce PT; Smith R; Campbell J
    Endocrinology; 1989 Oct; 125(4):2224-6. PubMed ID: 2551643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
    Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
    Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital and acquired syndromes of apparent mineralocorticoid excess.
    Edwards CR; Walker BR; Benediktsson R; Seckl JR
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.
    Funder JW; Pearce PT; Smith R; Smith AI
    Science; 1988 Oct; 242(4878):583-5. PubMed ID: 2845584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex.
    Moisan MP; Seckl JR; Edwards CR
    Endocrinology; 1990 Sep; 127(3):1450-5. PubMed ID: 2387261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
    Bonvalet JP; Doignon I; Blot-Chabaud M; Pradelles P; Farman N
    J Clin Invest; 1990 Sep; 86(3):832-7. PubMed ID: 2394832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase.
    Walker BR; Campbell JC; Williams BC; Edwards CR
    Endocrinology; 1992 Aug; 131(2):970-2. PubMed ID: 1639034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of renal 11 beta-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor.
    Stewart PM; Whorwood CB; Barber P; Gregory J; Monder C; Franklyn JA; Sheppard MC
    Endocrinology; 1991 Apr; 128(4):2129-35. PubMed ID: 1848510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [11 beta-hydroxysteroid dehydrogenase and steroid receptors].
    Takeda R; Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):658-64. PubMed ID: 1516720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone.
    Morris DJ; Souness GW
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F756-9. PubMed ID: 2316675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies.
    Rundle SE; Funder JW; Lakshmi V; Monder C
    Endocrinology; 1989 Sep; 125(3):1700-4. PubMed ID: 2547593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.
    Krozowski ZS; Funder JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6056-60. PubMed ID: 6310613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11 beta-Hydroxysteroid dehydrogenase activity in the hippocampus: implications for in vivo corticosterone receptor binding and cell nuclear retention.
    van Haarst AD; Welberg LA; Sutanto W; Oitzl MS; de Kloet ER
    J Neuroendocrinol; 1996 Aug; 8(8):595-600. PubMed ID: 8866246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's disease of the kidney.
    Lancet; 1988 Oct; 2(8618):1002. PubMed ID: 2902435
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase.
    Benediktsson R; Walker BR; Edwards CR
    Curr Opin Nephrol Hypertens; 1995 Jan; 4(1):41-6. PubMed ID: 7743156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
    Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.